The impact of androgen receptor pathway inhibitors as starting treatment in metastatic castration-sensitive prostate cancer on patient outcomes (OASIS Japan)

Abstract We examined the impact of starting treatment on clinical outcomes in men with metastatic castration-sensitive prostate cancer (mCSPC). This retrospective observational cohort study used claims data from the Medical Data Vision (MDV) hospital-based administrative dataset in Japan. All patien...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	Masaki Shiota, Yanfang Liu, Suneel Mundle, Mehregan Nematian-Samani, Jason Hwang, Xiayi Wang, Hirotsugu Uemura
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-04-01
Subjects:	Androgen receptor signalling inhibitors Apalutamide Metastatic castration-sensitive prostate cancer Overall survival
Online Access:	https://doi.org/10.1038/s41598-025-93136-9